Retatrutide's Impact on Obesity and Chronic Low Back Pain Under Study | Retatrutide News

Eli Lilly is studying retatrutide for chronic low back pain in obese or overweight individuals. The trial spans 80 weeks but specific efficacy data is n...
Clinical Trials · October 22, 2026